Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants

GAITHERSBURG, Md., Aug. 30, 2021. Novavax, Inc. , a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Centers for Disease Control and Prevention (CDC) has provided updated...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials